Wednesday, February 9, 2011

Weaning off cardiopulmonary bypass (CPB)

Weaning a patient off cardiopulmonary bypass (CPB) is an important step of cardiac surgical procedures. Emergence from CPB is a time for planned action and cooperation among the cardiac operating team. Returning heart and lungs to the circulation after CPB may represent a potential stress to the heart.
Most techniques, conduction and management of CPB are well standardized; however, separating patients from perfusion occasionally involves decisions based on empirical therapies. Weaning off CPB is a straightforward process that requires no particular measures other than reestablishing ventilation to the lungs and slowly turning the arterial pump off. In a number of cases however, weaning may be specially difficult, and in a few situations simply impossible.
Separation of CPB may require special protocols, in accordance to the status of the patients, to their particular age group and the conduction of bypass. Weaning off small children after prolonged, difficult and complex operations may represent a challenge to the surgical team.
Weaning off CPB is always conducted in a coordinate fashion. The surgeon directs the weaning process with some input from anesthesia and perfusion. A skillful anesthesiologist usually shares the control of weaning with the surgeon. This allows the surgeon to direct full attention to the grafts position, valve function, security of suture lines and final gross hemostasis. When this arrangement fails or there is no free communication in the team, it is not unusual while separating a patient from bypass to observe a perfusionist retaining more volume into a hypotensive patient while the anesthesiologist administers a vasopressor, both ignoring the surgeon's observation that the heart is distending.
Inadequate weaning and separation from CPB can prolong recovery and increase morbidity and mortality. 



PREPARING FOR WEANING
CPB is associated with various insults to normal physiology. These include anticoagulation, hemodilution, hypothermia, ischemic or chemical cardiac arrest, increased release of endogenous cathecolamine, vasopressin and other vasoactive substances, electrolyte disturbances, platelet activation, aggregation and destruction, and activation of complement and other plasma protein systems. These multiple interacting factors represent a number of potential routes for myocardial dysfunction or injury [1].
Weaning process is initiated after adjustment of certain patient variables, such as temperature, tissue oxygenation, hematocrit level, acid-base and electrolytes status, and cardiac function. Requirements of analgesic, narcotic and paralyzing drugs usually increase during rewarming and the necessary adjustments are made with avoidance of myocardial and circulatory depressant agents [2].
While most steps of weaning are standard and common to all cases, evaluation of cardiac function may disclose situations which will require specific measures such as the use of temporary pacemaker, inotropic or vasoactive drugs or mechanical support.

Temperature
Cardiopulmonary bypass is systematically accompanied by heat loss to the environment, even when hypothermia is not employed. Preparation for terminating CPB includes rewarming of patients to the normal or near normal temperature. Rewarming should be initiated as early as necessary so that its completion coincides with completion of the surgical procedure or soon afterwards. Patient temperature is monitored in at least two sites such as nasopharingeal, tympanic, esophageal, rectal or bladder. The most common combination is nasopharingeal and rectal temperatures.
As nasopharingeal temperature reaches 36.5 to 370C, rectal temperature is usually two to three degrees lower. A larger than four degrees gradient between the nasopharingeal and rectal temperatures is indicative of inadequate rewarming or increased vasoconstriction. In these situations there may occur a two to three degrees decrease in nasopharingeal temperature during sternal closure and transfer to intensive care unit, which may predispose the patients to unstable cardiac rhythm, shivering, and hypertension [3,4]. This afterdrop results from redistribution of heat within the body as the normal pulsatile blood flow opens up some relatively colder and constricted vascular beds [1,2].
A slow infusion of vasodilators (sodium nitroprusside) may provide a more homogenous rewarming and reduce the occurrence of significant temperature gradients. Pulsatile flow may promote the same results [5]. Warming blankets will not always be effective to correct the temperature drift, due to the increased peripheral constriction; small children may better benefit from warming blankets and ventilation with heated and humidified gases.
Hohn et cols [6] investigated 86 patients to draw the influence of warming the skin during weaning. Patients warmed through a water blanket and a blow of warm air to the head, in addition to the heat exchanger, had a better thermal balance and a lower blood loss, when compared to a control group.


Tissue oxygenation
Metabolic abnormalities are corrected before initiating the weaning process. Venous line carries true mixed venous blood, and venous oxygen saturation and PO2 are satisfactory indicators of tissue metabolism. Arterial PO2 and saturation best reflect the oxygenator performance.
Increased lactate production, decreased pH, and decreased mixed venous saturation and PO2 are indicators of inadequate tissue perfusion or oxygenation. A venous oxygen saturation of 75% and a minimum venous PO2 of 35mmHg are satisfactory to start weaning from CPB.

Hematocrit
Hemodilution is universally accepted as an important adjunct to cardiopulmonary bypass. Blood viscosity and oncotic pressure are reduced while tissue perfusion and oxygenation and cerebral flow are enhanced by the levels of hemodilution commonly used in clinical settings. Hematocrit values from 20 to 25% are usual with most perfusion protocols. By the end of rewarming, depending on renal function and the use of diuretics hematocrit may reach 24 to 30%.
Hearts with severe preoperative myocardial dysfunction will perform better immediately after termination of CPB with a hematocrit level above 34%. Red cells transfusion during rewarming may be necessary to adjust the hematocrit prior to discontinuing perfusion [7]. Under special circumstances or while perfusing small babies, a very low hematocrit can be corrected by transoperative ultrafiltration.

Acid base status
Regardless of the lowest temperature attained or the acid-base management protocol used (alpha or pH stat) during CPB, by the end of rewarming a pH of 7.4 and a PCO2 higher than 35 mmHg are mandatory to safely disconnect a patient from the pump.
Any degree of acidosis should promptly be corrected because it depresses myocardial contraction, diminishes the action of inotropes, and increases pulmonary vascular resistance.

Electrolytes
Potassium is the critical ion that may present acute changes during CPB, followed by calcium. Others ions rarely show significant changes and their correction is less demanding for the weaning to take place.
Hyperkalemia may result in atrioventricular block. Blood cardioplegia usually produces a higher potassium level at the end of perfusion. In the presence of a normal renal function, a mild hyperkalemia represented by a serum level of 6 mEq/L or less, will not require special treatment and resolve spontaneously. In the presence of a heart block or bradicardia, a more regular rhythm should be secured with temporary pacemaker wires. The hyperkalemia should be treated with insulin, glucose and furosemide [2,3].
Hypokalemia may predispose to atrial and ventricular arrhythmias, and shall be treated. During CPB it is preferable to administer potassium chloride in small frequent doses instead of continuous infusion. Doses of 5 mEq may be repeated after proper evaluation of serum levels.
Ionized calcium levels usually decrease during CPB and appears to recover fast thereafter. Administration of calcium chloride was widely employed in the past during separation from perfusion, because of its positive inotropic effect. Elevated serum calcium levels have been associated with increased vascular resistance on the peripheral, coronary, renal and cerebral microcirculation [1,8]. Calcium chloride administration has been associated with coronary arteries and mammary grafts spasms and is usually avoided in the revascularized patient. Some concern exists as to the potential role of an elevated serum calcium level in the aggravation of reperfusion injury [9].
Valvular and pediatric patients with a sluggish myocardial contraction frequently show some transient improvement after a small bolus (10 to 15mg/Kg) of calcium chloride immediately before discontinuing CPB.

Cardiac action
Several interacting factors of perfusion predispose the myocardium to injury and dysfunction. A certain amount of myocardial injury may be added after aortic unclamping, during the reperfusion phase. The period immediately before complete separation from bypass is critical; its duration is conditioned by myocardial recovery. Regardless of the myocardial protection strategy and method, even short periods of aortic cross-clamping can be followed by temporary functional depression.
Usually there is a mild and transient functional impairment shortly followed by resumption of effective cardiac action. Most hearts will benefit from a short period of supportive CPB, usually from 15 to 20 minutes for each hour of clamping. This is easily accomplished by properly timing surgery and rewarming [1,3,10].
When normal temperature is reached and preparations for weaning are completed, maximal myocardial recovery from the arrest period has usually been attained.
Cardiac function immediately prior to discontinuing perfusion is usually assessed by visual observation, electrocardiogram, ventricular filling pressures and afterload, and transesophageal echocardiography if available. Simple visual observation of heart action can provide valuable information on myocardial performance. Experienced teams can accurately predict the chances of immediate difficulties to terminate CPB by visually inspecting the heart action alone.
All clinical variables involved with cardiac performance (heart rate, preload and afterload, and contractility) are assessed in order to optimize cardiac output.
Cardiac rhythm and the adequacy of ventricular rate are evaluated by the electrocardiogram. Slow ventricular rates are adjusted by ventricular pacing; atrioventricular dissociation is corrected by atrioventricular sequential pacing.
Preload is evaluated by ventricular filling pressures. Left ventricular preload is inferred from left atrial mean pressure or pulmonary artery diastolic pressure; right atrial pressure reflects the preload conditions of right ventricle. During weaning preload is pump-dependent and can be adjusted by balancing blood volume between patient and oxygenator.
Ventricular afterload is evaluated by the status of peripheral vascular resistance. This is represented by the ratio between mean systemic arterial pressure and pump flow. Elevated peripheral resistance may require vasodilators. An occasional patient will present in a state of deep vasodilation and hypotension even when pump flow is adequate or elevated [11]. These will require a vasoconstrictor infusion to restore a normal peripheral resistance.
Transesophageal echocardiography (TEE) is useful to verify the adequacy of surgical repair in congenital and valvular cases; it can also offer valuable information on ventricular volumes and the quality of myocardial contractility [12].
Ninomiya et cols [13] assessed continuous transesophageal echocardiography monitoring during weaning from CPB in 41 children. They measured left ventricular ejection fraction, wall motion and end-diastolic volume. In the presence of severe heart failure, the authors could adjust drugs and mechanical support oriented by the TEE information. Shankar et cols [14] found epicardial ultrasound examination of paramount importance to detect less than perfect coronary translocations after Jatene's operation.

TERMINATION OF CPB
After adjusting cardiac rhythm and rate, preload and systemic arterial resistance, the assessment of cardiac function immediately before terminating CPB allows the patients to be classified into 3 groups. The proportion of patients on each group will depend on case distribution. According to our retrospective experience [15], a general surgical service dealing with the broadest spectrum of patients, which includes elderly, reoperations, emergencies and neonates will result in an approximate 70% of patients in group A, 25% in group B and 5% in group C.
Group A: Patients that will obviously offer no difficulty to disconnect from perfusion. For these patients, after reestablishing ventilation to the lungs, pump flow can be gradually reduced while venous return to the oxygenator is decreased until bypass is minimal. Arterial pump is stopped and venous line is clamped. Final adjustment of cardiac performance is made off pump, by slowly administering residual volume from the oxygenator until ideal preload is attained. These patients maintain an adequate cardiac output, as can be confirmed by normal atrial and arterial pressures, arterial and venous blood gases and pH and adequate spontaneous diuresis.
Most teams will administer a slow infusion of an inotrope (dopamine or dobutamine) or, less frequently a vasodilator, based only on "routine" protocol or "past" experience. This infusion is usually discontinued as the patient arrives to the intensive care area or is maintained for a few hours thereafter.
Group B: Patients with a mild to moderate degree of cardiac dysfunction that will require some support to disconnect from the pump. This support may be physiological (Starling law) or pharmacological (inotropes, vasodilators or both). Some patients in this group can benefit from intra-aortic balloon pumping [16,17].
Group B patients require a more elaborated protocol for CPB termination. Final preparations are made on partial bypass.
Before turning pump off all clinical determinants of cardiac performance are evaluated and adjusted, in order to optimize cardiac output. Blood volume is adjusted according to left atrial or pulmonary artery pressures and inotropes are commenced. Peripheral resistance is estimated and vasodilators or constrictors are instituted as required. After the drugs effectiveness is assessed, pump flow is decreased in small increments while venous return in proportionately adjusted to maintain a constant filling pressure. Arterial pump is stopped and venous line is clamped.
Most patients in group B will perform as well as group A patients. Some patients may have to return to pump for better adjustment of drugs, or to have an intra-aortic balloon inserted if a marginal cardiac output is present, as demonstrated by atrial and arterial pressures, arterial and venous blood gases and pH, and spontaneous diuresis.
Children with preoperative high pulmonary blood flow, children after a heart transplant, and some adults with long standing congestive heart failure may present with pulmonary hypertension that precludes successful weaning. Inhalation of nitric oxide (NO) has been demonstrated as dramatically improving cardiac output and allowing a smooth discontinuance of CPB [18, 19].
Bauer et cols [20] evaluated the efficacy of prostaglandin E1 as a poweful adjunt to wean difficult transplanted children with right ventricular failure.
The association of epinephrin in a slow infusion and nitroprusside or another vasodilator drug, possibly represents the strongest available stimulus to improve myocardial contractility.
A recently introduced inotrope (enoximone) is under evaluation to provide phrmacological support during weaning of patients with severe ventricular dysfunction [21,22].
An occasional patient in group B will not tolerate CPB termination even after a few trials. These few exceptions turn into group C patients.
Group C: Patients with severe cardiac dysfunction that will prove difficult to be removed from CPB, despite physiologic and pharmacological support. For these patients CPB will have to be prolonged. A few hours of circulatory assistance and intensive inotropic and vasodilator drugs therapy may turn some of these patients into group B. The remaining patients are candidates to a form of total circulatory mechanical support (if available) or they will not likely survive disconnection from pump [23,24,25].
Group C patients are by definition the hardest cases to manage. A few of these patients by the end of rewarming will have minimal or no cardiac activity which precludes any trial of disconnection from pump. The remaining patients may be given a short trial off pump after optimization of preload, afterload and contractility by a criterious combination of inotropes and vasoactive agents. Some of these patients will tolerate CPB removal, under maximal physiological and pharmacological support, and a few in the group may be further improved by an intra-aortic balloon pump. The patients with minimal cardiac activity and those in whom the trial off pump was unsuccessful are temporarily maintained on cardiac support with the heart-lung machine. A few hours on pump support may be a sufficient rest period to allow recovery of cardiac function and removal of CPB support in a small number of cases. For the others, a decision has to be made as to either advance to a mechanical device for prolonged support or terminate the efforts to recover cardiac action.
Children supported by full veno-arterial extracorporeal membrane oxygenation (ECMO) post cardiotomy, have a poor long term survival rate [26] when compared with children managed with centrifugal ventricular assist devices [27].


CONCLUSION
Weaning and disconnecting CPB is a team effort and requires clear planning and integrated performance. Despite being a simple procedure, interrupting perfusion can be elaborated, extremely difficult or virtually impossible. Resources for prolonged supportive bypass and mechanical devices shall be made available and their application to the difficult situations should be a part of CPB protocols.

SUMMARY
Weaning off cardiopulmonary bypass is a simple process; however, it may occasionally prove very difficult and sometimes virtually impossible. Preparation for weaning includes the adjustment of several patient related variables such as temperatures, tissue oxygenation, hematocrit, pH, electrolytes, and cardiac rhythm and rate. Cardiac action as routinely assessed will allow patients to be classified into 3 groups. Group A includes patients which will obviously offer no difficulties to remove from CPB. Group B comprises patients with mild to moderate dysfunction; they will require some physiological (Starling law) or pharmacological (inotropes, vasoactive drugs) support to be disconnected from pump. Group C are the patients with poor or no cardiac action, which will require either an aggressive pharmacological support or prolonged mechanical support as alternatives to sustain life.< p align=justify> Resources for prolonged supportive bypass and mechanical devices shall be available and their application to difficult situations should be part of CPB protocols.

Thursday, January 13, 2011

COmprehensive Mitral Valve Apparatus Reconstruction.

COMVAR is a surgical procedure that is developed to preserve the mitral valve.
COMVAR can treat mitral valve diseases, e.g., mitral insufficiency, mitral stenosis, and combined
mitral steno-insufficiency.
COMVAR is an acronym of COmprehensive Mitral Valve Apparatus Reconstruction.


The goal of COMVAR is to reconstruct the patient's native mitral valve apparatus anatomically and physiologically, instead of resection and replacement.

Depending on the patient's pathologic conditions, all or some of the above surgical steps are performed.
Mitral valve repair has been done commonly in the cardiac surgery. Nevertheless, COMVAR procedure provides the
uniform standardized modality in treating various types of mitral valve diseases, preserving the native mitral valve
structure as much as possible, because it restores not only mitral annulus, but also reconstructs the mitral leaflets. COMVAR procedure using the Mitra-Lift® series and COMVAR templates can be applied to the following cases.
1) Isolated mitral regurgitation
Isolated mitral regurgitation is a good indication and prolapsed leaflet regardless its location
(anterior or posterior, or both).
2) Isolated mitral stenosis
Isolated mitral stenosis even with annular calcifications can be managed by COMVAR technique together with
meticulous decalcification procedures.
3) Combined mitral regurgitation and stenosis
Regardless of its causative and initiating disease, once the mitral annulus, valve leaflet, or chorda is involved
pathologically, all of them are supposed to be diseased as time passes. Diseases such as mitral regurgitation,
stenosis, and combined steno-insufficiency belong to this category. COMVAR technique can be successfully
applied to these indications.
4) Prosthetic valve failure at the aortic position
Conditions with present artificial heart valve can be indicated for COMVAR, if the patient's mitral annulus has
been preserved.



COMVAR procedure is composed of 4 surgical steps.
1. Restoration of mitral annulus (lifting annuloplasty)
2. Reconstruction of chordae (chordoplasty)
3. Reconstruction of mitral valve leaflets (leaflet extension)
4. Restoration of mitral commissure (commissuroplasty)




ntraoperative sequence of COMVAR procedure
1. Left atriotomy (trans-atrial or trans-septal)
2. Submitral apparatus correction (chordoplasty) 
3. Mitral commissurotomy in mitral stenosis (commissuroplasty) 
4. Mitral leaflet extension (posterior and/or anterior)
5. Anterior annulus diameter measurement and determination
6. Posterior lifting annuloplasty
7. Removal of the product
Established techniques for cardiopulmonary bypass are used in the usual manner.
The followings are the specific procedures in the COMVAR procedure.
COMVAR (Comprehensive Mitral Valve Apparatus Reconstruction) procedure is performed in the
following order;

To expose the mitral valve and chordae, left atriotomy by either trans-atrial or trans-septal approach is possible.
1.Left atriotomy
Left atriotomy can be performed by either trans-atrial or trans-septal approach to expose the mitral valve structures adequately.
However, in case of small left atrium or combined tricuspid pathology, trans-septal approach allows much better exposure of mitral structures.
2.Submitral apparatus correction (chordoplasty)
When the chorda is torn by either endocarditis or degenerative reasons causing mitral insufficiency, neo-chordae
reconstruction can be done by conventional way using PTFE sutures.
3.Mitral commissurotomy (commissuroplasty) 
In case of mitral stenosis, commissurotomy can be perfomed anteriorly as well as posteriorly as needed.
Fused commissures can be divided until to reach the mitral annulus (Fig.1).
4. Mitral leaflet extension
-To be updated-
5. Anterior annulus diameter measurement and determination
To determine the length of mitral posterior lifting annuloplasty strip (Mitra-Lift®), anterior annulus diameter
should be measured from trigone to trigone using Mitral Sizers.
6. Posterior lifting annuloplasty
Lifting annuloplasty is a key procedure in MR, increasing the physiologic coaptation surface in systolic phase and elevates downward displaced LV free wall.
Specially designed structure of Mitra-Lift® strip is placed at the LA wall along the posterior annulus (Fig. 4).
7. Removal of the Product
After operation, the implanted device can be monitored and evaluated by Transesophageal Echocardiography or
Magnetic Resonance Imaging.If the implants are found to be wrongly located, or displaced after operation,
implants should be removed through the previous route and re-implanted or replaced with other new implant.
When endocarditis occurs in the annulus of mitral valve before neo-intima is created by the endothelialization process, implanted products are easy to be removed. Simply cut the knot of sutures on the strip and
take them out. However, when endocarditis occurs after endothelialization is completed, neo-intima has to be surgically opened to remove the encapsulated strip. The other processes are same.

Advantage of COMVAR
Technically Easy and SafeIn comparison with the conventional prosthetic mitral valve replacement technique,
this standardized COMVAR technique helps surgeon operate in comfort.
Minimizes Functional Impairment of mitral valve apparatusCOMVAR can preserve the function of mitral valve apparatus without prosthetic mitral valve replacement.
Obviates Anticoagulation
Anticoagulant is unnecessary; no danger of blood clots.
Excellent ApplicabilityCOMVAR is applicable to all kinds of Mitral Valve diseases including severely calcified or thickened Mitral stenosis.
Preserves Hemodynamics
COMVAR ensures the normal function of cardiac valve and whereby it leads to ideal blood pressure and blood flow.
COMVAR can also gurantee the sufficiency of mitral orifice.
Improves Quality of LifeQuick recovery from surgical operation and low rate of recurrence ensure active and energetic life.
Tissue Compatibility: reduces the threat of endocarditisAs COMVAR® Set is made of Dacron in form of flexible strips, it can endure repetitive contraction and relaxation of mitral annulus and does not give any stress on the tissues.

Procedure of CARVAR





Indications of CARVAR?
Aortic valve repair has been considered as the challenging area in the cardiac surgery.
But CARVAR procedure provides the uniform standard modality in treating various types of
aortic root and valve diseases, preserving the native aortic root and valve structure
as much as possible, because it restores not only aortic root cage, but also reconstructs
the aortic leaflets.CARVAR procedure using the Rootcon® and
Leafcon® series can be applied to the following cases
1) Isolated aortic valve disease
Isolated aortic regurgitation is a good indication and aortic stenosis can also be indicated, even though severe
calcification and leaflet distortion are present.
- Aortic Valve Insufficiency
- Aortic Valve Stenosis
- Annulo-Aortic Ectasia (including Marfan Syndrome)
2) Combined aortic root and valve disease 
Regardless of its causative and initiating disease, once the aortic root or valve is involved pathologically, both
aortic root and valve are supposed to be all diseased as time passes. Diseases such as aortic aneurysm,
annuloaortic ectasia, aortic dissection belong to this category.
CARVAR technique also can be successfully applied to these cases.
- Aortic Aneurysm (ascending aorta, descending aorta)
- Aortic Dissection
- Infective Endocarditis
3) Prosthetic valve failure at the aortic position
Conditions with present artificial heart valve can be indicated for CARVAR,
if the patient's aortic root has been preserved.
- Other aortic valve diseases


CARVAR procedure is largely composed of 3 surgical steps.
1. retention of appropriate aortic annulus size
2. restoration of appropriate sinotubular junction size
3. reconstruction of aortic valve leaflets 

Depending on the patient's pathologic condition, all or some of the above surgical steps are performed.

For example, in most cases for aortic regurgitation, step 1 is not needed.
But in most cases for aortic stenosis or aortic valve leaflet prolapsed, step 2 and 3 should be performed.
In most cases for aortic dissection and ascending aortic aneurysm,
step 2 and ascending aorta replacement are enough to do.

1. Peri-root dissection

The aortic root should be first dissected and freely mobilized with complete resection of fatty tissue attatched to
the aortic root and its neighboring structures before aortotomy. If the coronary arteris are "high take -off" type,
sub-coronary dissection is recommended.
2. Aortotomy
If the ascending aorta is hugely dilated like in the annuloaortic ectasia, ascending aortic aneurysm and aortic
dissection, the ascending aorta is transected. But if the ascending aorta is not dilated or slightly to moderately
dilated, the ascending aorta is incisied partially and anteriorly.
The level of aortotomy is usually 7~10㎜ above the sinotubular junction. If the coronary arteries take off high,
then the level of aortotomy is 7~10㎜ above the origin of coronary arteries.
3. Annulus diameter measurement
The annulus diameter is measured with the Annulus Sizer 011 series.
The aortic annulus is composed of fibrous annulus and muscular annulus. First, measure the length of muscular
annulus. When the muscular annulus is measured, measure the circumferential length from the commissure
between noncoronary leaflet and right coronary leaflet to the mid-point of left coronary leaflet (Fig. 4).
Next, measure the opposite fibrous annulus in the similar manner and compare it with the length of muscular
annulus. Then, make the length of muscular annulus as a reference because the ratio of the length of fibrous
versus muscular part is approximately 1:1 in the normal condition (Fig. 5). 
If the muscular annulus is dilated and ejection fraction (EF) is less than 30%, it may be attributed to
a kind of cardiomyopathy. Consider a cardiac transplantation instead of CARVAR procedure.)


4. STJ diameter measurement and determination of ideal STJ diameter.
The STJ diameter is measured with the Sciencity STJ Sizer 012 series. There can be two situations:
(1) aortic leaflets look like normal and
(2) aortic leaflets are deteriorated like in the calcified aortic stenosis.
When the aortic leaflets look like normal, 3 leaflets are pulled together by a single stitch (Frater's stitch) that is
passed through the 3 nodules of Aranti (center of leaflet margin), and measure the leaflet surface (Fig. 6).
If STJ diameter is measured in the aortic aneurysm and dissection, the level of STJ is determined just above
the level of commissures. When the aortic leaflets are deteriorated, cut them to open the commissural fusion
and remove the calcifed mass sufficient enough to mobilize the leaflets and then measure the STJ diameter in the
manner that sizer can be passed without resistance (Fig. 7).
Select the one as large as possible of these diameters, considering that the ratio of Annulus/STJ diameter is
normally within the range 1.0 ~1.2.


5. Annulus reduction (Annuloplasty)
If the fibrous annulus is not dilated, this procedure is not needed (Table 1).
But if the annulus part is dilated larger than muscular part by 2㎜ more, reduce it to the length of muscular
annulus. Also in all Marfan patients (annuloaortic ectasia), the fibrous annulus have to be always reduced.
The same numbered strip as the length of muscular annulus measured is selected.
For example, if the length of muscular annulus is measured 30㎜, then select the Rootcon® Annulus In 30 strip.
After peeling off the lid of the package, remove the strip with its holder and separate the strip from the holder.
Six 4-0 polypropylene double-armed sutures are evenly placed on the Rootcon® Annulus In 30 strip and then
passed through the aortic annulus wall and come out of the aortic root, so that 2 suture in left coronary leaflet
and 4 suture in noncoronary leaflet are approximately placed. Then, select the +6 numbered Annulus Out strip,
that is, 36 and call for Annulus Out strip 36 and remove the strip with its holder from package and place
the above sutures in order sequence on the Annulus Out strip 36. After separating the Annulus Out 36 strip from
its holder, pull out all 6 sutures and push down the Annulus Out 36 strip and make alignment with the Annulus In
30 strip and tie tightly (Fig. 8).
6. Aortic leaflet reconstruction
If aortic valve leaflets are normal, skip this step (Table 1). But when the aortic valve leaflets are distorted and
diseased, resect the aortic leaflets. Often the subaortic membrane over the muscular annulus can be present in
severe aortic stenosis. Then resect it at the same time.
When the aortic leaflets are resected, decide the resection type or range among the following 3 methods,
depending on the scope of the disease involvement.
1) Complete resection down to the annulus
2) Partial resection to 2~3㎜ away from the annulus
3) Leaflet extension without resection of diseased leaflet
Resect all 3 leaflets, rather than leaving 1 or 2 leaflets. New leaflets are reconstructed with bovine or
glutaraldehyde-fixed autologous pericardium.
It is very convenient to use the template (Leafcon®) for designing the pericardial patch. When template is used,
select the same numbered template as the number of STJ diameter measured and the same type of template as
the resection type performed. There are provided 3 types of template in concordance with resection type,
C-Leafcon®, P-Leafcon®, and E-Leafcon® for each size (Fig. 9).
For example, if the diameter of STJ was determined as 28㎜ and leaflets were partially resected,
select the #28 P-type template(P-Leafcon® 28) among 3 types of template.
Then place the bovine or glutaraldehyde-fixed autologous pericardium between the plates of selected template
and cut the pericardium along the margin of the template with the scissors.
(See the User’s manual of Leafcon® Set) Attach the cut pericardial cusp to the remnant of the aortic leaflet with
continuous 5-0 polypropylene sutures (Fig. 10).
7. Commissure reduction (Commissuroplasty)
After new leaflets are reconstructed, commissuroplasty is added in the following manner in order to compress or
reduce a commissural gap and subcommissural triangle. Three 4-0 pledget-reinforced mattress sutures are placed
through the adjacent edges of the newly reconstructed pericardial leaflets at each commissural level.
These sutures can be externalized outside the aorta and secured (Fig. 11).
8. STJ reduction
STJ reduction should be always carried out in CARVAR procedure. But only when the aortic stenosis without STJ
dilatation (STJ diameter <24㎜) is corrected, STJ reduction is done enoughly with the outer strip (STJ Out)
without inner ring (STJ In) (Table 1). Otherwise, both of inner and outer ring or strip are together used. The size
selection of STJ inner ring (STJ In) is automatically determined by the diameter of STJ measured. When the size
of STJ outer ring or strip is selected, it is determined as the +6 numbered STJ outer ring in the usual cases but if
the aortic root is huge-dilated or involved by dissection, select the +8 numbered STJ outer ring (STJ Out) or
open STJ outer strip (STJ Out Strip 40). Also, when the aorta is partially incised, it is convenient to use the open
STJ Out Strip 40. For example, if the diameter of STJ is measured 28㎜, select the same numbered STJ In 28.
Then, select +6 ~ +8 numbered STJ Out Ring, that is STJ Out Ring 34 or 36. Normally STJ ring or strip is located
5mm above the ostia of coronary artery. But if the coronary artery is highly taken off just like in the huge aortic
aneurysm, STJ reduction should be performed in the sub-coronary position.
When STJ is reduced, there can be 2 types of situations:
(1) complete transection of ascending aorta and
(2) anterior partial incision of ascending aorta. When the asceding aorta is completely transected,
inner ring is inserted with three 4-0 double-armed orientaional mattress sutures which pass through the aortic wall
from the inner ring. (There are 3 equidistant vertical marks for alignment with commissures
and another 3 mid-way marks between them on the ring) Next, another three 4-0 mattress mid-way sutures are
placed between the orientational sutures. Additional two 4-0 mattress sutures are placed mid-way between each
orientational and mid-way sutures. These sutures in due order are passed through the outer ring or strip and
tied (Fig. 12 and 13). When the ascending aorta is anteriorly and partially incised, outer strip is first placed behind
the dissected aortic root and 3 orientational sutures are first placed from the inner ring through the aortic wall to
the outer strip and tied. Again, 3 mid-way mattress sutures encompassing the inner ring, aortic wall and outer
strip are placed mid-way between the orientational sutures and tied. In the regular order, 12 additional sutures
are placed between them in the same manner and tied (Fig. 14) 
9. New leaflets coaptation sutures
5-0 polypropylene sutures are passed over and over the adjacent pericardial new leaflets near
the each commissural region and externalized outside the aorta and tied to make the new commissures (Fig. 15).
10. Removal of the product 
Evaluation on the implanted device after operation can be achieved by Transesophageal Echocardiography or Multi-Channel CT or Magnetic Resonance Imaging.If the implants are wrongly located, or if the implant is displaced after operation, implants can be removed through the previous route and reimplanted or replaced with other new implant. When endocarditis occurs in the aortic root before neo-intima is created by endothelialization process, implanted ring and/or strip are easy to be removed. Simply cut the knot of sutures on the ring/strip and take them out. However, when endocarditis occurs after endothelialization is completed, neo-intima has to be surgically opened to remove the encapsulated ring/strip. The other processes are same.



Advantage of CARVAR
Technically Easy and Safe In comparison with the conventional prosthetic aortic valve replacement technique, this standardized
CARVAR technique helps surgeon operate in comfort.
Minimizes Functional Impairment of Aortic RootCARVAR Set (Rootcon® series and Leafcon® series) can preserve the function of Aortic Root without prosthetic aortic valve replacement.
Obviates Anticoagulation
Anticoagulant is unnecessary; no danger of blood clots.
Preserves Hemodynamics (Reduces Progression of Aortic Valve Regurgitation)CARVAR Set (Rootcon® series and Leafcon® series) ensures the normal function of cardiac valve and whereby it leads to ideal blood pressure and blood flow.
Improves Quality of Life
Quick recovery from surgical operation and low rate of recurrence ensure active and energetic life.
Tissue Compatibility: reduces the threat of endocarditisAs CARVAR Set (Rootcon® series and Leafcon® series) is made of Dacron in form of flexible bands and strips, it can endure repetitive contraction and relaxation of aorta and does not give any stress on the tissues.